Clinical impact of the cell-of-origin classification based on immunohistochemistry criteria and Lymph2Cx of diffuse large B-Cell lymphoma patients in a South-east Asian population: a single center experience and review of the literature-Reference-Cited by-同舟云学术

Clinical impact of the cell-of-origin classification based on immunohistochemistry criteria and Lymph2Cx of diffuse large B-Cell lymphoma patients in a South-east Asian population: a single center experience and review of the literature

Published:2019-10-19 Issue:12 Volume:12 Page:1095-1105
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Lee Joanne¹²,Hue Susan Swee-Shan³⁴,Ko Stephanie Q⁵,Tan Soo Yong³⁶,Liu Xin¹,Girard Louis-Pierre⁷,Chan Esther Hian Li¹,De Mel Sanjay¹,Jeyasekharan Anand¹⁸,Chee Yen Lin¹²,Koh Liang Piu¹²,Poon Li Mei¹²

Affiliation:

1. Department of Haematology-Oncology, National University Health System, Singapore, Singapore

2. Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

3. Department of Pathology, National University Health System, Singapore, Singapore

4. Science Technology and Research Singapore, Institute of Molecular and Cellular Biology, Singapore

5. Department of Medicine, National University Health System, Singapore, Singapore

6. Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore

7. School of Medicine, University of Aberdeen, Aberdeen, UK

8. Cancer Science Institute, National University of Singapore, Singapore

Publisher

Informa UK Limited

Subject

Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2019.1677152

Reference55 articles.

1. The 2016 revision of the World Health Organization classification of lymphoid neoplasms

2. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

3. Pathogenesis of Human B Cell Lymphomas

4. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unmet Needs in the First-Line Treatment of Diffuse Large B-cell Lymphoma: Expert Recommendations From the Asia-Pacific Region With a Focus on the Challenging Subtypes;Clinical Lymphoma Myeloma and Leukemia;2024-09

2. Routine application of the Lymph2Cx assay for the subclassification of aggressive B-cell lymphoma: report of a prospective real-world series;Virchows Archiv;2022-10-11

3. An integrated prognostic model for diffuse large B‐cell lymphoma treated with immunochemotherapy;eJHaem;2022-05-03

4. Bcl-6-dependent risk stratification by nuclear expression of Peli1 in diffuse large B-cell lymphoma;Journal of Cancer;2022

5. Quality control for immunohistochemistry and in situ hybridization: how to know if the color change is signal or background;In Situ Molecular Pathology and Co-Expression Analyses;2021